Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-01

Clinical Trial Update: Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether folic acid and creatine can lower blood arsenic in individuals with chronic arsenic exposure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)
  • folic acid (folic acid)

Snippet

Sponsor: Columbia University | Conditions: High Blood Arsenic Due to Chronic Arsenic Exposure | Phase 4 | Status: COMPLETED